SIMCERE PHARMA (02096) spent 10.1667 million Hong Kong dollars to repurchase 1.49 million shares on November 18th.
Sinopharm (02096) announced that on November 18, 2024, the company invested 1016.67 million...
SIMCERE PHARMA (02096) announced that on November 18, 2024, the company repurchased 1.49 million shares at a cost of 10.167 million Hong Kong dollars. The repurchase price was between 6.71 and 6.98 Hong Kong dollars per share.
Related Articles
OURGAME (06899) clarifies the voluntary announcement on October 14th: AGAE is a joint venture company of the group and will resume trading on the afternoon of October 15th.
CHINA LILANG (01234): The retail amount of "LILANZ" products in the third quarter recorded a low double-digit increase compared to the same period last year.
ZTO EXPRESS-W (02057) expended 8.3555 million US dollars to repurchase 450,100 shares on October 14th.
OURGAME (06899) clarifies the voluntary announcement on October 14th: AGAE is a joint venture company of the group and will resume trading on the afternoon of October 15th.
CHINA LILANG (01234): The retail amount of "LILANZ" products in the third quarter recorded a low double-digit increase compared to the same period last year.
ZTO EXPRESS-W (02057) expended 8.3555 million US dollars to repurchase 450,100 shares on October 14th.
RECOMMEND
